Next Article in Journal
Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [211At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care
Previous Article in Journal
Development and Validation of Monte Carlo Methods for Converay: A Proof-of-Concept Study
Previous Article in Special Issue
Agreement Between High-Risk Human Papillomavirus Testing in Paired Self-Collected and Clinician-Collected Samples from Cervical Cancer Screening in Spain
 
 
Article

Article Versions Notes

Cancers 2025, 17(7), 1188; https://doi.org/10.3390/cancers17071188
Action Date Notes Link
article pdf uploaded. 31 March 2025 18:09 CEST Version of Record https://www.mdpi.com/2072-6694/17/7/1188/pdf-vor
article xml file uploaded 2 April 2025 07:43 CEST Original file -
article xml uploaded. 2 April 2025 07:43 CEST Update https://www.mdpi.com/2072-6694/17/7/1188/xml
article pdf uploaded. 2 April 2025 07:43 CEST Updated version of record https://www.mdpi.com/2072-6694/17/7/1188/pdf
article html file updated 2 April 2025 07:46 CEST Original file https://www.mdpi.com/2072-6694/17/7/1188/html
Back to TopTop